Relationship between miRNA‑433 and SPP1 in the presence of fracture and traumatic brain injury

Han,Zhen; Shi,Feng; Chen,Ya; Dong,Xiaoqing; Zhang,Bo; Li,Meng

doi:10.3892/etm.2021.10360

Relationship between miRNA‑433 and SPP1 in the presence of fracture and traumatic brain injury

Authors:
- Zhen Han
- Feng Shi
- Ya Chen
- Xiaoqing Dong
- Bo Zhang
- Meng Li
View Affiliations

Affiliations: First Aid Center, Jinan Zhangqiu District People's Hospital, Jinan, Shandong 250200, P.R. China, Department of Pharmacy, Jinan Zhangqiu District People's Hospital, Jinan, Shandong 250200, P.R. China
Published online on: June 30, 2021 https://doi.org/10.3892/etm.2021.10360
Article Number: 928
Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Limb fracture combined with traumatic brain injury (TBI) is one of the most common multiple injuries and patients often suffer from severe craniocerebral injury combined with long bone fracture of the limbs. The present study examined the expression of osteopontin (SPP1) in the tibial fracture callus and heterotopic ossification tissues in craniocerebral injury and investigated its relationship with miR‑433. A total of 26 patients with tibial fracture combined with brain injury were included in the TBI group, and 26 patients with simple tibial fracture were included in the control group. The patients received immobilization treatment and callus was collected during the operation. At the time of steel plate removal tissue ossification samples from patients with heterotopic ossification were collected. Peripheral blood was collected from all patients on the morning of the operation day. Expression of miR‑433 and SPP1 mRNA was determined by reverse transcription‑quantitative PCR and SPP1 protein expression was measured by western blotting. Dual luciferase reporter assay was used to identify the direct interaction between miR‑433 and SPP1 mRNA. The human osteoblast line hFOB1.19 was transfected with agomiR‑433 to overexpress miR‑433 and expression of SPP1 was also examined. TBI enhanced the incidence of callus formation and heterotopic ossification in patients with fracture but did not alter fracture healing time. SPP1 mRNA and protein expression was elevated in patients who had tibial fracture in combination with craniocerebral injury in comparison with controls By contrast, expression of miR‑433 was decreased in patients who had tibial fracture in combination with craniocerebral injury in comparison with controls. miR‑433 regulated the expression of SPP1 mRNA and protein by directly binding to the 3'‑untranslated region of SPP1 mRNA. The present study suggests that SPP1 mRNA and protein levels are increased in the callus, heterotopic ossification tissues and plasma from patients with tibial fracture combined with brain injury in comparison with controls. This elevation may be due to the reduced expression of miR‑433.

View Figures

View References

1	Li Z, Zhao J, Luo W, Li K, Lei S and Wang Y: Nrp-1 expression in healing process of traumatic brain injury combined with tibial fracture. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 42:154–160. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
2	Kobylecki C, Glasse H, Amin J, Gregson CL, Lyell V and Henderson EJ: Fracture risk assessment in atypical parkinsonian syndromes. Mov Disord Clin Pract. 8:385–389. 2021.PubMed/NCBI View Article : Google Scholar
3	Brady RD, Grills BL, Church JE, Walsh NC, McDonald AC, Agoston DV, Sun M, O'Brien TJ, Shultz SR and McDonald SJ: Closed head experimental traumatic brain injury increases size and bone volume of callus in mice with concomitant tibial fracture. Sci Rep. 6(34491)2016.PubMed/NCBI View Article : Google Scholar
4	Jodoin M, Rouleau DM, Therrien E, Chauny JM, Sandman E, Larson-Dupuis C, Leduc S, Gosselin N and De Beaumont L: Investigating the incidence and magnitude of heterotopic ossification with and without joints involvement in patients with a limb fracture and mild traumatic brain injury. Bone Rep. 11(100222)2019.PubMed/NCBI View Article : Google Scholar
5	Boes M, Kain M, Kakar S, Nicholls F, Cullinane D, Gerstenfeld L, Einhorn TA and Tornetta P III: Osteogenic effects of traumatic brain injury on experimental fracture-healing. J Bone Joint Surg Am. 88:738–743. 2006.PubMed/NCBI View Article : Google Scholar
6	Pang X, Gong K, Zhang X, Wu S, Cui Y and Qian BZ: Osteopontin as a multifaceted driver of bone metastasis and drug resistance. Pharmacol Res. 144:235–244. 2019.PubMed/NCBI View Article : Google Scholar
7	Chen G, Zhang X, Li R, Fang L, Niu X, Zheng Y, He D, Xu R and Zhang JZ: Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum. 62:2900–2908. 2010.PubMed/NCBI View Article : Google Scholar
8	Gao SG, Li KH, Zeng KB, Tu M, Xu M and Lei GH: Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthritis Cartilage. 18:82–87. 2010.PubMed/NCBI View Article : Google Scholar
9	Gattorno M, Gregorio A, Ferlito F, Gerloni V, Parafioriti A, Felici E, Sala E, Gambini C, Picco P and Martini A: Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis. Rheumatology (Oxford). 43:1091–1096. 2004.PubMed/NCBI View Article : Google Scholar
10	Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, Xu WH and Wang HB: Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. J Cell Physiol. 234:18587–18601. 2019.PubMed/NCBI View Article : Google Scholar
11	Yu H, Sun H, Wang Z and Liu Y: MicroRNA let-7a up-regulates OPN expression in a mouse model of allergic rhinitis. J Laryngol Otol. 131:955–960. 2017.PubMed/NCBI View Article : Google Scholar
12	Liu Y, Qian K, Li C, Ma Y and Chen X: Roles of microRNA-539 and osteopontin in rheumatoid arthritis. Exp Ther Med. 15:2681–2687. 2018.PubMed/NCBI View Article : Google Scholar
13	Jiang K, Teng GD and Chen YQ: MicroRNA-23 suppresses osteogenic differentiation of human bone marrow mesenchymal stem cells by targeting the MEF2C-mediated MAPK signaling pathway. J Gene Med. 22(e3216)2020.PubMed/NCBI View Article : Google Scholar
14	Tao L, Bei Y, Chen P, Lei Z, Fu S, Zhang H, Xu J, Che L, Chen X, Sluijter JP, et al: Crucial role of miR-433 in regulating cardiac fibrosis. Theranostics. 6:2068–2083. 2016.PubMed/NCBI View Article : Google Scholar
15	Zhang T, Jiang K, Zhu X, Zhao G, Wu H, Deng G and Qiu C: miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a. Int J Biol Sci. 14:622–632. 2018.PubMed/NCBI View Article : Google Scholar
16	Shi Q, Wang Y, Mu Y, Wang X and Fan Q: MiR-433-3p inhibits proliferation and invasion of esophageal squamous cell carcinoma by targeting GRB2. Cell Physiol Biochem. 46:2187–2196. 2018.PubMed/NCBI View Article : Google Scholar
17	Sun S, Wang X, Xu X, Di H, Du J, Xu B, Wang Q and Wang J: MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma. Oncotarget. 8:5057–5068. 2017.PubMed/NCBI View Article : Google Scholar
18	Rolfs F, Piersma SR, Dias MP, Jonkers J and Jimenez CR: Feasibility of phosphoproteomics on leftover samples after RNA extraction with guanidinium thiocyanate. Mol Cell Proteomics. 20(100078)2021.PubMed/NCBI View Article : Google Scholar
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
20	Zhao D, Chen H and Wang B: Assessing the regulatory functions of LncRNA SNHG11 in gastric cancer cell proliferation and migration. Front Cell Dev Biol. 9(620476)2021.PubMed/NCBI View Article : Google Scholar
21	Einhorn TA and Gerstenfeld LC: Fracture healing: Mechanisms and interventions. Nat Rev Rheumatol. 11:45–54. 2015.PubMed/NCBI View Article : Google Scholar
22	Dey D, Wheatley BM, Cholok D, Agarwal S, Yu PB, Levi B and Davis TA: The traumatic bone: Trauma-induced heterotopic ossification. Transl Res. 186:95–111. 2017.PubMed/NCBI View Article : Google Scholar
23	Micha D, Voermans E, Eekhoff ME, van Essen HW, Zandieh-Doulabi B, Netelenbos C, Rustemeyer T, Sistermans EA, Pals G and Bravenboer N: Inhibition of TGFβ signaling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease. Bone. 84:169–180. 2016.PubMed/NCBI View Article : Google Scholar
24	Lin YH and Yang-Yen HF: The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem. 276:46024–46030. 2001.PubMed/NCBI View Article : Google Scholar
25	Wang KX and Denhardt DT: Osteopontin: Role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19:333–345. 2008.PubMed/NCBI View Article : Google Scholar
26	Shao H, Wu R, Cao L, Gu H and Chai F: Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): A therapeutic implication in osteoporosis. Bioengineered. 12:960–968. 2021.PubMed/NCBI View Article : Google Scholar
27	Wang J, Gao Z and Gao P: MiR-133b modulates the osteoblast differentiation to prevent osteoporosis via targeting GNB4. Biochem Genet, Mar 9, 2021 (Online ahead of print).
28	He HP and Gu S: The PPAR-γ/SFRP5/Wnt/β-catenin signal axis regulates the dexamethasone-induced osteoporosis. Cytokine. 143(155488)2021.PubMed/NCBI View Article : Google Scholar
29	Foster BL, Ao M, Salmon CR, Chavez MB, Kolli TN, Tran AB, Chu EY, Kantovitz KR, Yadav M, Narisawa S, et al: Osteopontin regulates dentin and alveolar bone development and mineralization. Bone. 107:196–207. 2018.PubMed/NCBI View Article : Google Scholar
30	Ma C, Wei F, Xia H, Liu H, Dong X, Zhang Y, Luo Q, Liu Y and Li Y: MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition. Int J Oncol. 50:1739–1748. 2017.PubMed/NCBI View Article : Google Scholar
31	Zhao X, Mohan R, Özcan S and Tang X: MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. J Biol Chem. 287:31155–31164. 2012.PubMed/NCBI View Article : Google Scholar
32	Chen K and Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 8:93–103. 2007.PubMed/NCBI View Article : Google Scholar
33	Li J, Chen M and Yu B: miR-433 suppresses tumor progression via Smad2 in non-small cell lung cancer. Pathol Res Pract. 215(152591)2019.PubMed/NCBI View Article : Google Scholar
34	Zhao YF, Li MX, Chang GZ and He XH: ERK on apoptosis of gastric cancer cells induced by microRNA-433. Zhonghua Yi Xue Za Zhi. 98:3954–3957. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
35	Liang T, Guo Q, Li L, Cheng Y, Ren C and Zhang G: MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1. Neoplasma. 63:696–704. 2016.PubMed/NCBI View Article : Google Scholar
36	Yang Z, Tsuchiya H, Zhang Y, Hartnett ME and Wang L: MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. J Biol Chem. 288:28893–28899. 2013.PubMed/NCBI View Article : Google Scholar
37	Guo LH, Li H, Wang F, Yu J and He JS: The tumor suppressor roles of miR-433 and miR-127 in gastric cancer. Int J Mol Sci. 14:14171–14184. 2013.PubMed/NCBI View Article : Google Scholar
38	Lin X, Rice KL, Buzzai M, Hexner E, Costa FF, Kilpivaara O, Mullally A, Soares MB, Ebert BL, Levine R and Licht JD: miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation. Leukemia. 27:344–352. 2013.PubMed/NCBI View Article : Google Scholar
39	Tang X, Lin J, Wang G and Lu J: MicroRNA-433-3p promotes osteoblast differentiation through targeting DKK1 expression. PLoS One. 12(e0179860)2017.PubMed/NCBI View Article : Google Scholar
40	Kim EJ, Kang IH, Lee JW, Jang WG and Koh JT: MiR-433 mediates ERRγ-suppressed osteoblast differentiation via direct targeting to Runx2 mRNA in C3H10T1/2 cells. Life Sci. 92:562–568. 2013.PubMed/NCBI View Article : Google Scholar
41	Smith SS, Dole NS, Franceschetti T, Hrdlicka HC and Delany AM: MicroRNA-433 dampens glucocorticoid receptor signaling, impacting circadian rhythm and osteoblastic gene expression. J Biol Chem. 291:21717–21728. 2016.PubMed/NCBI View Article : Google Scholar
42	Simon D, Laloo B, Barillot M, Barnetche T, Blanchard C, Rooryck C, Marche M, Burgelin I, Coupry I, Chassaing N, et al: A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia. Hum Mol Genet. 19:2015–2027. 2010.PubMed/NCBI View Article : Google Scholar
43	Wang P and Zhang Z: Bone marrow-derived mesenchymal stem cells promote healing of rabbit tibial fractures via JAK-STAT signaling pathway. Exp Ther Med. 19:2310–2316. 2020.PubMed/NCBI View Article : Google Scholar
44	Liu S, Huang Y, Tian S, Zhang W, Xu Y and Ge J: Hyperhomocysteinemia inhibits tibial fracture healing in rats through PI3K/AKT signaling pathway. Exp Ther Med. 19:2083–2088. 2020.PubMed/NCBI View Article : Google Scholar
45	Qiao J, Zhou M, Li Z, Ren J, Gao G, Cao G, Shen H and Lu S: Comparison of remote ischemic preconditioning and intermittent hypoxia training in fracture healing. Mol Med Rep. 19:1867–1874. 2019.PubMed/NCBI View Article : Google Scholar